AllianceBernstein’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
KCM
RHJA
PHP
AllianceBernstein's OPRX Position: Q2 2026 in Review
AllianceBernstein sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 39,850 shares — an estimated $489K sold.
AllianceBernstein first reported a position in OPRX in Q4 2020 and held it in 21 quarters. The position peaked at $1.45M in Q3 2021. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.
- AllianceBernstein reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
- AllianceBernstein sold 39,850 OptimizeRx shares in Q2 2026, an estimated $489K.
- AllianceBernstein first reported a position in OptimizeRx in Q4 2020 and held it in 21 quarters.
- AllianceBernstein's OptimizeRx position peaked at $1.45M in Q3 2021.
- 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.